Coronavirus impact: 14 July - plenty of updates and a bizarre response from Manolete
Plenty of results and updates today, including a robust response from Manolete Partners, an insolvency litigation financing firm, to an article which questioned its results and reporting.
Manolete: why bother responding!
Previous article Next article
DON'T MISS OUT!
Get top investment ideas to help safeguard and grow your wealth.
Invaluable insight from the exciting world of smaller companies.
REGISTER FREE
More on AdEPT Technology
As frustrating as ever
News from AIM covered here, include results from one of AIM’s more elderly companies and one…
Focus on the cash flow
Results and updates from AIM companies covered here extend from the fast growers to…
Results and updates from AIM companies covered here extend from the fast growers to…
Some welcome good news at last for shareholders in this provider of online competitions to win…
Yet another highly valued retail play, which only joined AIM a year ago, has seen its…
Plenty of results and updates today, including a robust response from Manolete Partners, an insolvency litigation financing firm,…
This AIM listed connected healthcare group has delivered excellent results and the growing focus on data…
Results and updates covered here include a disappointing outlook for a company which runs online competitions.…
Results and trading updates from AIM covered in our free update here are generally positive and include plenty…
It was good to see the senior management of several companies covered here take…
Results and updates covered here include yet more disappointment for shareholders of online wine retailer Naked…
Our coverage here includes several modestly valued companies whose shares should recover strongly when the world…
Updates covered here include news of more big share purchases from a founder and CEO of…
This innovative med tech company has secured much needed funding to get it through the sale…
Focus on the cash flow
Better than expected
Another IPO from 2021 tumbles
Coronavirus impact: 14 July - plenty of updates and a bizarre response from Manolete
Loads of cash and heaps of potential
Not the best, but hardly the worst either
Plenty to encourage | Bonkers Bargain Upgrades
Big sell-off brings Director buying!
Naked Wines: stripping shareholders bare
Vaccine countdown update: 12 Nov - apparent value here and probably a few traps
More Director buying to encourage
Sensyne gets its dosh | Valuations!
More Company Insights
As frustrating as ever
Focus on the cash flow
Shares take a bath
Plenty of promise in these results and updates
Focus on the cash flow
Better than expected
Plenty of waffle
Dieselgate could deliver big returns for this company
Another IPO from 2021 tumbles
Coronavirus impact: 14 July - plenty of updates and a bizarre response from Manolete
Coronavirus impact: 20 May - Boohoo founders spot an opportunity
Coronavirus impact:14 May - infection prevention is booming and we learn a new term
Loads of cash and heaps of potential
Not the best, but hardly the worst either
This AIM survivor is selective with the facts
ESG financing facility first of many
Plenty to encourage | Bonkers Bargain Upgrades
Big sell-off brings Director buying!
Results are coming thick and fast
Inflationary boost | Solid start | What’s coming?
Naked Wines: stripping shareholders bare
Vaccine countdown update: 12 Nov - apparent value here and probably a few traps
Vaccine countdown update: 10 Nov - positive results from some, cash flow concerns with others
Coronavirus impact: 14 July - plenty of updates and a bizarre response from Manolete
More Director buying to encourage
Sensyne gets its dosh | Valuations!
AIM’s global leader and a smaller alternative
Vaccine countdown update: 10 Nov - positive results from some, cash flow concerns with others
More Company Insights
Plenty to encourage | Bonkers Bargain Upgrades
Bonkers Bargains: positive update and still amazing value
Stonking Small Caps: positive update
